Melanotan I
Worth trying, BioHarmony verdict
BioHarmony score 6.2 out of 10
Melanotan I is most defensible for photoprotection in EPP and planned UV exposure, with Langendonk 2015 reporting 69.4 vs 40.8 hours of pain-free sun exposure in the US trial. The wellness case is narrower than the prescription afamelanotide evidence.
Read full reportWhat is Melanotan I?
Melanotan I (Afamelanotide) is a synthetic MC1R-selective alpha-MSH analog with prescription-grade evidence for erythropoietic protoporphyria, where Langendonk reported 69.4 versus 40.8 hours of pain-free sun exposure in the US Phase III arm. Afamelanotide works by increasing eumelanin through MC1R, which explains why the upside is strongest for photoprotection and pigment-related use cases. Melanotan I earns a worth-trying score because regulated SCENESSE has meaningful human evidence and the intrinsic afamelanotide safety profile is manageable with dermatology monitoring.
From the BioHarmony report, reviewed Sep 8, 2026.
Saved on this device only.
How it is thought to work
MC1R activation increases eumelanin and UV tolerance
Safety watch-outs
- New or rapidly changing mole, oral pigmentation, or bleeding lesion
- Severe headache, confusion, vision change, chest pain, or neurologic symptoms
- Priapism, severe abdominal pain, dark urine, or muscle pain after dosing
Full risk profile in the BioHarmony report.
Dosing as published
Source-reported figures only. This page does not calculate a personal dose.
Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.
More reported protocols
MembersMembers can compare additional reported doses, schedules, and preparation notes.
Educator coverage (2)
Attributed viewpoints, separate from primary research.
- International Peptide Society 2018 Compound Curriculum Dr. William Seeds,
- Melanotan 1 vs Melanotan 2: Which Peptide Is Right for You? Jay Campbell,
Trust & sourcing
- Last revieweddone
- Next reviewupcoming
The registry alias Melanotan I maps to afamelanotide. FDA-approved afamelanotide is marketed as Scenesse to increase pain-free light exposure in adults with erythropoietic protoporphyria, not as a general tanning product.
Primary sources
- Scenesse (afamelanotide) prescribing information U.S. Food and Drug Administration,
Related peptides for skin & hair
- 6.5AHK-Cu (Copper Tripeptide)AHK-Cu is a topical copper tripeptide, Alanine-Histidine-Lysine plus copper, marketed for hair growth.
- 6.2SNAP-8SNAP-8 (acetyl octapeptide-3) is a topical cosmetic peptide sold as a Botox alternative.
- 7.2GHK-Cu (Copper Peptide)GHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…
- 6.4KPV (Lysine-Proline-Valine)KPV is a three-amino-acid alpha-MSH fragment that reduced inflammation in mouse colitis models through PepT1 uptake and NF-kB pathway suppression, but it still has zero…
The Ultimate Peptides Guide
Spot stronger candidates, weak evidence, and seller red flags before you buy.